Tredaptive News
Most Popular Tredaptive Story
Merck's cholesterol drug wins European OK
Merck's cholesterol drug Tredaptive - known as Cordaptive in the U.S. -- has won European approval. The 1g/20mg modified-release tablets are a new lipid-modifying therapy for patients with... Read more...
Latest Headlines
- July 15, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
